Concert Pharma (CNCE) Misses Q4 EPS by 7c

Concert Pharma (NASDAQ: CNCE) reported Q4 EPS of ($0.86), $0.07 worse than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c